Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
11.3M
-
Shares change
-
-909K
-
Total reported value, excl. options
-
$24.5M
-
Value change
-
-$5.12M
-
Number of buys
-
40
-
Number of sells
-
-21
-
Price
-
$2.17
Significant Holders of Metagenomi, Inc. - COM (MGX) as of Q3 2024
75 filings reported holding MGX - Metagenomi, Inc. - COM as of Q3 2024.
Metagenomi, Inc. - COM (MGX) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 11.3M shares
.
Largest 10 shareholders include Novo Holdings A/S (1.8M shares), RA CAPITAL MANAGEMENT, L.P. (1.31M shares), FARALLON CAPITAL MANAGEMENT LLC (1.06M shares), PFM Health Sciences, LP (1.03M shares), CITADEL ADVISORS LLC (804K shares), HHLR ADVISORS, LTD. (778K shares), Sozo Ventures GP II, L.P. (582K shares), BlackRock, Inc. (436K shares), MILLENNIUM MANAGEMENT LLC (418K shares), and VANGUARD GROUP INC (374K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.